Abstract: | The title compound, (S)‐(+)‐4‐[5‐(2‐oxo‐4,5‐dihydroimidazol‐1‐ylsulfonyl)indolin‐1‐ylcarbonyl]anilinium chloride (S)‐(+)‐1‐[1‐(4‐aminobenzoyl)indoline‐5‐sulfonyl]‐4‐phenyl‐4,5‐dihydroimidazol‐2‐one, C24H23N4O4S+·Cl?·C24H22N4O4S, crystallizes in space group C2 from a CH3OH/CH2Cl2 solution. In the crystal structure, there are two different conformers with their terminal C6 aromatic rings mutually oriented at angles of 67.69 (14) and 61.16 (15)°. The distances of the terminal N atoms (of the two conformers) from the chloride ion are 3.110 (4) and 3.502 (4) Å. There are eight distinct hydrogen bonds, i.e. four N—H?Cl, three N—H?O and one N—H?N, with one N—H group involved in a bifurcated hydrogen bond with two acceptors sharing the H atom. C—H?O contacts assist in the overall hydrogen‐bonding process. |